Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials.
Saved in:
| Title: | Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials. |
|---|---|
| Authors: | Jhanji V; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Duncan J; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Gardner T; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Hughes GK; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., McIntire R; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Peña AM; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Ladd C; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Gardner B; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Moore T; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Garrett E; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma., Cook C; Department of Dermatology, University of Oklahoma Medical Center, Oklahoma City, Oklahoma., Haslam A; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California., Prasad VK; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California., Vassar M; Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.; Department of Psychiatry and Behavioral Sciences, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma. |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2025 Nov 03; Vol. 24 (11), pp. 1701-1711. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
